FDAnews
www.fdanews.com/articles/96545-emea-completes-the-review-of-recombinant-factor-viii-products-and-inhibitor-development

EMEA Completes the Review of Recombinant Factor VIII Products and Inhibitor Development

July 31, 2007

The European Medicines Agency (EMEA) has completed a review of data on recombinant factor VIII (FVIII) products and the risk of the development of inhibitors against these products.
EMEA